Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 1,616 | 1,408 | 1,392 | 3,967 | 1,314 |
| Cost of Goods | 931 | 608 | 756 | 1,412 | 703 |
| Gross Profit | 685 | 800 | 636 | 2,555 | 611 |
| Operating Expenses | 10,077 | 7,771 | 8,129 | 5,728 | 11,646 |
| Operating Income | -8,461 | -6,363 | -6,737 | -2,761 | -10,332 |
| Interest Expense | 1,094 | 652 | 709 | 804 | 857 |
| Other Income | 4,297 | 3,804 | -221 | -258 | -59 |
| Pre-tax Income | -5,258 | -3,211 | -7,667 | -3,823 | -11,248 |
| Net Income Continuous | -5,258 | -3,211 | -7,667 | -3,823 | -11,248 |
| Net Income | $-5,258 | $-3,211 | $-7,667 | $-3,823 | $-11,248 |
| EPS Basic Total Ops | -0.08 | -0.05 | -0.11 | -0.07 | -0.19 |
| EPS Basic Continuous Ops | -0.08 | -0.05 | -0.11 | -0.06 | -0.19 |
| EPS Diluted Total Ops | -0.08 | -0.05 | -0.11 | -0.07 | -0.19 |
| EPS Diluted Continuous Ops | -0.08 | -0.05 | -0.11 | -0.06 | -0.19 |
| EBITDA(a) | $-7,677 | $-5,765 | $-6,345 | $-2,316 | $-9,837 |